Search results for "PATIENT"

showing 10 items of 5265 documents

Predictive value of IL-6 and IL-10 serum levels in anastomotic leakage in elderly patients undergoing surgery for colorectal cancer

2009

Methods The study group is yet represented by 33 patients: 17 males and 16 females (median age 76, range 70–89). The location of cancer was respectively: 5 (15, 15%) in the rectum, 15 (45, 45%) in the left colon, 11 (33, 33%) in the right colon, 1 (3, 3%) in the transverse colon, 1 (3, 3%) synchronous in the caecum and the sigmoid colon. The associated diseases observed were: chronic obstructive pulmonary disease, hypertension, diabetes mellitus, ischemic heart disease arterial vasculopathy.

medicine.medical_specialtyAnastomotic leakage IL-6 IL-10 elderly patients surgerybiologyColorectal cancerbusiness.industryTransverse colonCancerRectumSigmoid colonDiseaselcsh:Geriatricsmedicine.diseaseGastroenterologydigestive system diseaseslcsh:RC952-954.6Settore MED/18 - Chirurgia Generalemedicine.anatomical_structureDiabetes mellitusInternal medicineMeeting Abstractmedicinebiology.proteinGeriatrics and GerontologyInterleukin 6business
researchProduct

SPLIT-LUNG VOLUMETRY IN PATIENTS AFTER SINGLE-LUNG TRANSPLANTATION USING 3HELIUM-MRI 

2000

medicine.medical_specialtyAnesthesiology and Pain Medicinebusiness.industryLung volumetrymedicineIn patientRadiologySingle Lung TransplantationbusinessAnesthesiology
researchProduct

A C1-inhibitor rare mutation: Early diagnosis of hereditary angioedema in a paediatric patient

2013

Hereditary angioedema secondary to C1-inhibitor deficiency is a rare autosomal dominant disorder characterized by a deficiency of C1 esterase inhibitor.An eight-year-old girl showed periorbital painless swelling, diagnosed as ethmoiditis. A craniofacial scan did not evidence a paranasal sinus involvement, C1INH levels were undetectable, with low C4 levels: 7.6 mg/dl and C1INH: <8.46 mg/dl. The genetic study identified a rare mutation of the C1INH gene. This clinical report is of relieve because paediatric cases described in literature are rare, did not presented a positive family history, and received a diagnosis after many attacks. Furthermore our girl received a prompt diagnosis of HAE at…

medicine.medical_specialtyAngioedemabiologybusiness.industrymedicine.diseaseDermatologySurgeryC1-inhibitormedicine.anatomical_structureMutation (genetic algorithm)Hereditary angioedemamedicinebiology.proteinmedicine.symptomCraniofacialFamily historybusinessSinus (anatomy)Paediatric patientsOpen Journal of Pediatrics
researchProduct

Abnormal Nailfold Capillaries in Patients after Hand Transplantation

2020

Background: The development of graft vasculopathy may play a role in the long-term deterioration of hand grafts. The aim of study was to examine the patterns of the nailfold capillaries in hand transplant recipients. Methods: the study was performed on six patients who received hand transplantation. To normalize for the effect of immunosuppression an age- and sex-matched group of 12 patients with active kidney transplant was selected. As an additional control group, 12 healthy volunteers were recruited. Nailfold videocapillaroscopy was performed in all participants. Additionally, serum concentrations of vascular endothelial growth factor (VEGF) were measured. Results: Videocapillaroscopic e…

medicine.medical_specialtyAngiogenesismedicine.medical_treatmentVEGF receptorsUrologymicrovascular abnormalitieslcsh:Medicinenailfold capillaroscopy030230 surgeryArticle03 medical and health scienceschemistry.chemical_compoundangiogenesis0302 clinical medicineHealthy volunteersmedicineIn patient030203 arthritis & rheumatologybiologyvascular endothelial growth factorbusiness.industrylcsh:RImmunosuppressionGeneral MedicineSerum concentrationVascular endothelial growth factorsurgical procedures operativechemistrybiology.proteinbusinessHand transplantationhand transplantationJournal of Clinical Medicine
researchProduct

Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients

2018

The efficacy and safety of olmesartan medoxomil (OM) vs active control (AC) monotherapy among elderly patients aged 60‐79 years (N = 4487) was evaluated by meta‐analysis (25 studies). In all patients, change from baseline to end point in blood pressure (BP) was significantly greater with OM vs AC (−19.5/−11.9 vs −16.8/−10.7 mm Hg). Greater proportions of OM‐ vs AC‐treated patients achieved BP goals. In patients with impaired renal function (estimated glomerular filtration rate <60 mL/min/1.73 m(2)), OM treatment resulted in a greater mean change from baseline in systolic BP vs AC (−21.2 vs −18.7 mm Hg, respectively) and a greater proportion of patients achieving BP goals. These parameters w…

medicine.medical_specialtyAngiotensin receptorEndocrinology Diabetes and MetabolismUrologyRenal functionBlood Pressure030204 cardiovascular system & hematologyHypertension Therapy03 medical and health sciencesImpaired renal functionAngiotensin Receptor Antagonists0302 clinical medicineDiabetes mellitusInternal MedicinemedicineHumansIn patient030212 general & internal medicineAdverse effectAgedOlmesartan Medoxomilbusiness.industryMiddle Agedmedicine.diseaseBlood pressureTreatment OutcomeHypertensionCardiology and Cardiovascular MedicineOlmesartanbusinessmedicine.drug
researchProduct

Delayed brain reexpansion in schizophrenic patient affected by trabecular type chronic subdural hematoma

2021

Background: Chronic subdural hematoma (cSDH) represents a complex and unpredictable disease, characterized by high morbidity and mortality, especially in elderly patients. Factors affecting the postoperative brain reexpansion along to cSDH recurrence have not been yet adequately investigated. The authors presented the case of a schizophrenic patient affected by trabecular type cSDH that presented a delayed brain reexpansion despite a craniotomy and membranotomy. Case Description: A 51-year-old female patient with diagnosis of schizophrenia was admitted to the emergency department with GCS score of 5/15 and right anisocoria. An urgent brain CT revealed a trabecular right cSDH (35 mm in maxi…

medicine.medical_specialtyAnisocoriabusiness.industryPatient affectedmedicine.medical_treatmentTrabecularCase ReportChronic subdural hematomaEmergency departmentmedicine.diseaseSurgeryPneumocephalusChronic subdural hematomaMidline shiftSchizophreniaPneumocephalusSchizophreniamedicineSurgeryNeurology (clinical)medicine.symptombusinessCraniotomyCraniotomySurgical Neurology International
researchProduct

THU0476-HPR Perceived influence of health status on sexual activity in ankylosing spondylitis patients:

2013

Background Ankylosing spondylitis (AS) is a chronic, systemic inflammatory rheumatic disease which affects the axial skeleton, but may also affect peripheral joints, tendons and internal organs. The disease which begins in the second or third decade may give rise to significant loss of function and impaired quality of life. Sexuality is an important part of quality of life. Only a few studies have explored this issue in AS patients. In a rheumatoid arthritis (RA) cohort, (74% females, mean (SD) age 56.5 (14.2) years), 1/3 of the patients reported their health statues to have a considerable influence on their sexual activity (1). Objectives To examined the impact of perceived influence of he…

medicine.medical_specialtyAnkylosing spondylitisbusiness.industryImmunologyDiseasemedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyRheumatologyQuality of lifeInternal medicineRheumatoid arthritisCohortmedicinePhysical therapyImmunology and AllergyOutpatient clinicBASFIbusinessBASDAIAnnals of the Rheumatic Diseases
researchProduct

Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acqui…

2019

Antifibrinolytics combined with aPCC are not routinely administered to patients with acquired hemophilia A due to increased thrombotic risk. This association normalizes clot stability, and improves the efficacy of therapy, but can increase the risk of severe side effects. Due to these premises it has always raised doubts and perplexities in the clinics. We now report the data of the "FEIBA® on acquired haemophilia A Italian Registry (FAIR Registry)", a retrospective-prospective study that included 56 patients. This is the first study that assessed the clinical response of the combination of aPCC and antifibrinolytic agents in patients with acquired haemophilia A. A total of 101 acute bleeds…

medicine.medical_specialtyAntifibrinolyticmedicine.drug_classHemorrhage030204 cardiovascular system & hematologyHemophilia APremises03 medical and health sciences0302 clinical medicineDrug TherapyThromboembolismAntifibrinolytic agentInternal medicineActivated prothrombin complex concentrateAcquired haemophiliaThromboembolic riskHumansMedicineIn patientRegistries030212 general & internal medicineAcquired haemophilia AHematologybusiness.industryHematologyAcquired haemophilia A; Activated prothrombin complex concentrate; Antifibrinolytics; Thromboembolic risk; Antifibrinolytic Agents; Blood Coagulation Factors; Cardiovascular Diseases; Drug Therapy Combination; Hemophilia A; Hemorrhage; Humans; Registries; ThromboembolismAntifibrinolytic AgentsBlood Coagulation FactorsClinical trialTolerabilityCardiovascular DiseasesCombinationAntifibrinolyticDrug Therapy CombinationAntifibrinolyticsCardiology and Cardiovascular Medicinebusiness
researchProduct

Infectious complications in patients with myelodysplastic syndromes: A review of the literature with emphasis on patients treated with 5-azacitidine.

2017

Myelodysplastic Syndromes are oligo-clonal stem cell disorders that are associated with cytopenias in the peripheral blood. Major causes for morbidity and mortality in myelodysplastic syndromes (MDS) patients are infections mostly due to bacteria or fungi. Beside leucopenia per se in affected patients, function of white blood cells particularly that of neutrophils seems to be impaired. Here we summarize the available data on infections in MDS patients in general and particularly those treated with 5-azacitidine.

medicine.medical_specialtyAntimetabolites AntineoplasticNeutropeniaAzacitidineInfections03 medical and health sciences0302 clinical medicinehemic and lymphatic diseasesInternal medicineGranulocyte Colony-Stimulating FactormedicineHumansIn patientMortalityInfection Controlbusiness.industryMyelodysplastic syndromesHematologyGeneral MedicineAntibiotic Prophylaxismedicine.diseasePeripheral blood030220 oncology & carcinogenesisMyelodysplastic SyndromesAzacitidineStem cellMorbiditybusiness030215 immunologymedicine.drugEuropean journal of haematology
researchProduct

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

2007

Abstract Antimuscarinic therapy is the primary treatment for overactive bladder. Long-term persistence with the therapy can be problematical, and has been linked to both efficacy and tolerability. A number of specific contributory factors to poor persistence can be identified, such as adverse effects of medication, insufficient beneficial effects, inadequate follow-up after initiation of therapy (poor motivation), and unmet or unrealistic expectations (poor communication between the patient and physician). Open-label studies on antimuscarinics overestimate the real-life persistence, which can lead to unrealistic expectations of the physician. Dose flexibility has improved patient compliance…

medicine.medical_specialtyAntimuscarinic Agentbusiness.industryTransdermal patchUrologymedicine.diseasePatient satisfactionTolerabilityQuality of lifeOveractive bladderPillPhysical therapyMedicineAdverse effectbusinessIntensive care medicineEuropean Urology Supplements
researchProduct